Penetrating deep sclerectomy (combining deep sclerectomy with trabeculectomy) delivers promising intermediate results in the treatment of paediatric glaucoma, according to the conclusions of a study published in the January issue of Ophthalmology.
Penetrating deep sclerectomy (combining deep sclerectomy with trabeculectomy) delivers promising intermediate results in the treatment of paediatric glaucoma, according to the conclusions of a study published in the January issue of Ophthalmology.
Sylvain Roy, MD, PhD of the Jules Gonin Eye Hospital at the University of Lausanne, Switzerland and colleagues conducted a retrospective non-interventional case series study of paediatric (mean preoperative age, 3.6±4.5 years) glaucoma patients (n=28; eyes, n=35) undergoing combined deep sclerectomy and trabeculectomy surgery between March 1997 and October 2006. Patients - who were examined preoperatively, and then postoperatively at day 1, day 7 and at 1, 2, 3, 4, 6, 9 and 12 months, and every six months thereafter - were assessed for intraocular pressure (IOP) change, a change in the number of medications prescribed, complications, and surgical revisions, among other factors. The mean follow-up was 3.5±2.9 years.
Preoperatively, mean IOP was 31.9±11.5 mmHg, which had decreased by 58.3% at the end of follow-up. Sight-threatening complications were more common for patients with refractory glaucomas; the number of these complications was also associated with the severity of the condition and the number of previous surgeries. At nine years postoperatively, the complete success rate was 52.3%; the qualified success rate at this point was 70.6%.
The team concluded that these intermediate results of combined deep sclerectomy and trabeculectomy are promising, and noted that these results are more favourable than earlier treatments trialled for this indication.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.